M J Daemen

Author PubWeight™ 89.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999 4.85
2 Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997 4.00
3 Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001 2.93
4 Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 1995 2.46
5 Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 2001 2.38
6 Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 1999 2.25
7 The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 1999 2.06
8 Structural alterations in the latissimus dorsi muscles in three patients more than 2 years after a cardiomyoplasty procedure. Eur Heart J 1998 2.02
9 Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 2001 1.91
10 Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999 1.86
11 Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res 2001 1.83
12 Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 1998 1.69
13 The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 1994 1.68
14 Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 1993 1.66
15 The heart-brain connection: mechanistic insights and models. Neth Heart J 2013 1.56
16 Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats. Cardiovasc Res 1998 1.45
17 Tenascin and fibronectin expression in healing human myocardial scars. J Pathol 1996 1.40
18 Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand 2001 1.37
19 Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res 1999 1.32
20 Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998 1.21
21 Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 2000 1.18
22 Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci U S A 2000 1.16
23 Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 2000 1.16
24 Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiovasc Res 2000 1.10
25 DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991 1.05
26 Beta-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction. Am J Pathol 2000 1.05
27 Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res 1992 1.03
28 Cardiovascular phenotyping in mice. Cardiovasc Res 1998 1.02
29 Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am J Respir Crit Care Med 1998 1.02
30 Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J Biol Chem 1990 1.01
31 Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab Invest 1994 1.01
32 Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. Cardiovasc Res 2001 1.00
33 Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol 2001 0.99
34 The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol 2000 0.99
35 A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat Med 1997 0.99
36 Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters? Circulation 1996 0.97
37 Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 1992 0.96
38 Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol 1997 0.95
39 Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol 1996 0.93
40 Transmural changes in mast cell density in rat heart after infarct induction in vivo. J Pathol 1995 0.92
41 The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 0.90
42 Effects of chemical sympathectomy on angiotensin II-induced neointimal growth in the balloon-injured rat carotid artery. J Vasc Res 1998 0.89
43 Circumstances and causes of out-of-hospital cardiac arrest in sudden death survivors. Heart 1998 0.89
44 Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis? Circ Res 1994 0.87
45 Mitogenic effect of angiotensin II on rat carotid arteries and type II or III mesenteric microvessels but not type I mesenteric microvessels is mediated by endogenous basic fibroblast growth factor. Circ Res 1998 0.86
46 Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000 0.86
47 Perianal injection of polydimethylsiloxane (Bioplastique implants) paste in the treatment of soiling: pilot study in rats to determine migratory tendency and locoregional reaction. Dis Colon Rectum 1998 0.85
48 Evaluation of the membrane attack complex of complement for the detection of a recent myocardial infarction in man. J Pathol 2000 0.85
49 Acute and long-term effects of tissue culture on contractile reactivity in renal arteries of the rat. Circ Res 1989 0.85
50 Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 1995 0.85
51 Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia. Am J Respir Crit Care Med 2001 0.84
52 Angiotensin I converting enzyme inhibitors and cardiac remodeling. Basic Res Cardiol 1991 0.83
53 Anastomotic intimal hyperplasia in prosthetic arteriovenous fistulas for hemodialysis is associated with initial high flow velocity and not with mismatch in elastic properties. J Am Soc Nephrol 1995 0.82
54 Transforming growth factor-beta: a local or systemic mediator of plaque stability? Circ Res 2001 0.80
55 A new animal model to study intimal hyperplasia in arteriovenous fistulas. J Surg Res 1999 0.80
56 The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein. J Thorac Cardiovasc Surg 2001 0.80
57 Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated. Arterioscler Thromb Vasc Biol 1996 0.79
58 Doxazosin blocks the angiotensin II-induced smooth muscle cell DNA synthesis in the media, but not in the neointima of the rat carotid artery after balloon injury. Cardiovasc Res 1996 0.79
59 Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system. J Hypertens 1997 0.79
60 Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. Cardiovasc Res 1997 0.79
61 Sensitivity of graft rejection in rats to local immunosuppressive therapy. Transplantation 1988 0.79
62 Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation 1996 0.79
63 Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice. Pflugers Arch 2000 0.79
64 Chronic alpha 1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall. Modulation of responsiveness after vascular injury. Arterioscler Thromb Vasc Biol 1996 0.79
65 Cardiac remodeling in hypertension and following myocardial infarction: effects of arteriolar vasodilators. Basic Res Cardiol 1991 0.78
66 Mesenteric small artery changes after vasoconstrictor infusion in young rats. J Cardiovasc Pharmacol 1993 0.78
67 DNA synthesis in isolated arteries. Kinetics and structural consequences. Am J Physiol 1991 0.78
68 Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. J Cardiovasc Pharmacol 2001 0.78
69 Cardioprotective effects of the Na(+)/H(+)-exchange inhibitor cariporide in infarct-induced heart failure. Cardiovasc Res 2000 0.77
70 The effect of pentobarbitone anaesthesia and hypothermia on the hepatic clearance of indocyanine green and S(-)-acenocoumarol in the rat. J Pharm Pharmacol 1986 0.76
71 Interstitial fibrosis and angiotensin-converting enzyme inhibition in patients with end-stage myocardial infarction. J Am Coll Cardiol 1998 0.76
72 Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts. Cardiovasc Res 1998 0.76
73 Antihypertensive therapy and adaptive mechanisms in peripheral ischemia. Hypertension 1993 0.76
74 Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response? Br Heart J 1994 0.75
75 In vivo DNA synthesis is not uniformly increased in arterial smooth muscle of young spontaneously hypertensive rats. J Hypertens 1991 0.75
76 Effects of angiotensin II on cardiac function and peripheral vascular structure during compensated heart failure in the rat. Arterioscler Thromb Vasc Biol 1997 0.75
77 [The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease]. Ned Tijdschr Geneeskd 1998 0.75
78 Pharmacokinetic considerations in target-organ directed drug delivery. Trends Pharmacol Sci 1988 0.75
79 Local budesonide treatment of rat cardiac allografts results in effective immunosuppression without systemic immunological side effects. Transplant Proc 1990 0.75
80 Should we aim at tissue renin-angiotensin systems? Pharm World Sci 1998 0.75
81 Papillary mesothelioma of the albuginea testis. Urology 1994 0.75
82 Does ACE inhibition limit structural changes in the heart following myocardial infarction? Eur Heart J 1995 0.75
83 Peripheral vascular alterations during experimental heart failure in the rat. Do they exist? Arterioscler Thromb Vasc Biol 1995 0.75
84 [Organ-oriented administration of drugs; sense and nonsense]. Ned Tijdschr Geneeskd 1989 0.75
85 Morphological changes of the venous system in uremic patients. A histopathologic study. Nephron 1995 0.75
86 In vivo evaluation of the Hydrolyser hydrodynamic thrombectomy catheter. J Vasc Interv Radiol 1995 0.75
87 Target organ directed drug delivery: evaluation of renal infusion of chromium-51 ethylenediaminetetraacetate and sodium o-[125I]iodohippurate in the Wistar Kyoto rat. J Pharm Sci 1986 0.75
88 Apparent dose dependency of the hepatic (S)-acenocoumarol clearance in the rat: a study using open liver biopsies. J Pharm Sci 1986 0.75